ST-segment elevation acute coronary syndrome: angiographic and genetic research results
We enrolled 126 patients at the age of 39 to 85 who underwent primary percutaneous coronary intervention for ST-segment elevation acute coronary syndrome. Depending on the development of recurrent coronary events, we divided all patients into 2 groups: with recurrent coronary events (with a high cardiovascular risk, n = 40) and without recurrent coronary events (control group, n = 86). We studied the peculiarities of coronary artery lesions and the influence of АВСВ1 and CYP2C19 genetic polymorphisms.